Table 2.
Hospital and homecare therapy.
| Home Oral Therapy | Drug Posology |
|---|---|
| Ramipril (ACE inhibitor) | 10 mg, 1 cpr day |
| Fleiderina (anti-atrial fibrillation) | 200 mg, 1 cpr day |
| Lobivon (anti-hypertension) | 5 mg, 1 cpr day |
| Hospital therapy | Timeline |
| Kcl retard (oral) 600 mg | from 18 to 25 November |
| Norvasc (oral) 5 mg 1 cp | from 20 November in replacing Lobivon |
| Clexane (ID) 6000 1 fl day | from 20 November to 1 December |
| Pantorc (IV) 40 mg 1 fl day | from 18 November to 1 December |
| Decadron (IV) 8 mg 1 fl × 2 | from 18 to 26 November |
| Decadron (IV) 4 mg 1 fl × 2 | from 27 November to 1 December |
| Rocefin (IV) 2 g 1 fl | from 18 November to 1 December |
| Veklury (IV) 100 mg 2 fl + S.F. 250 mL in 2 h | from 15 November to 19 November |
| Veklury (IV) 100 mg 1 fl + S.F. 250 mL in 2 h | from 20 November to 23 November |
| O2 in CPAP (peep 10 cm H2O) + FiO2 | O2 Supplementation (%) |
| 60% (day 18 November) 50% (days from 20 to 25 November) 40% (day from 26 to 29 November) On 30 November, O2 supplementation ended. |